Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation

• Alice Clément-Zhao ,

  Roles Writing – original draft

  * E-mail: alice.clement313@gmail.com

  Affiliation Radiotherapy Department, Institut Curie, Paris, France

  http://orcid.org/0000-0002-3990-2576

  ⨯
• Marie-Laure Tanguy,

  Roles Data curation, Formal analysis

  Affiliation Biostatistics Department, Institut Curie, Paris, France

  ⨯
• Paul Cottu,

  Roles Data curation, Investigation

  Affiliation Oncology Department, Institut Curie, Paris, France

  ⨯
• Brigitte De La Lande,

  Roles Funding acquisition

  Affiliation Radiotherapy Department, Institut Curie, Rene Huguenin Hospital, Saint Cloud, France

  ⨯
• Patrick Bontemps,

  Roles Investigation

  Affiliation Radiotherapy Department, CHU Jean Minjoz, Besançon, France

  ⨯
• Claire Lemanski,

  Roles Funding acquisition, Investigation

  Affiliation Radiotherapy Department, Institut régional du Cancer de Montpellier, Montpellier, France

  ⨯
• Pierre Baumann,

  Roles Investigation

  Affiliation Radiotherapy Department, Centre d’Oncologie de Gentilly, Nancy, France

  ⨯
• Alexia Savignoni,

  Roles Formal analysis

  Affiliation Biostatistics Department, Institut Curie, Paris, France

  ⨯
• Christelle Levy,

  Roles Investigation

  Affiliation Radiotherapy Department, Centre François Baclesse, Caen, France

  ⨯
• Karine Peignaux,

  Roles Investigation

  Affiliation Radiotherapy Department, Centre Georges-François Leclerc, Dijon, France

  ⨯
• Agnès Reynaud-Bougnoux,

  Roles Investigation

  Affiliation Radiation Oncology Department, CHU Tours, Tours, France

  ⨯
• Aline Gobillion,

  Roles Formal analysis, Methodology, Validation

  Affiliation Biostatistics Department, Institut Curie, Paris, France

  ⨯
• Youlia Kirova

  Roles Conceptualization, Data curation, Funding acquisition, Investigation, Supervision

  Affiliation Radiotherapy Department, Institut Curie, Paris, France

  ⨯